Get The App!
Loading the player...
Is JAK inhibitor therapy beneficial in MF patients who have only mild symptoms and minimal splenomegaly?
Share by Email
Send to social websites
Report this video as inappropriate
You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email.
Select your reason
Violent or Repulsive Content
Hateful or Abusive Content
Harmful Dangerous Acts
Is it better to treat early to control the development of symptoms, or wait until symptoms worsen an...
What is the standard of care for first-line treatment of JAK (-) MF?
What are the most important factors to consider when selecting ruxolitinib dosage?
Typical Duration of Therapy with Ruxolitinib
Reasons People go off Ruxolitinib
Discussion on Combination Treatment Strategies
Discussion on Patients with Anemia who are Being Treated with Ruxolitinib
Treating Patients with Splenomegaly who are Already Anemic
Copyright 2020 by NSCI Group, Inc.
On The Go
About MedEd On The Go